INFINITY PHARMACEUTICALS, INC. (INFI) symbol metrics page

Infinity Pharmaceuticals Inc.. (INFI) NASDAQ

$0.02 - (-)

Market Cap: -

As of 09/29/23 12:00 AM EDT. Market closed.

(INFI)

Infinity Pharmaceuticals Inc.. (INFI)
NASDAQ

$0.02
- (-)

Market Cap: -

As of 09/29/23 12:00 AM EDT. Market closed.

Add to Portfolio

the mission of infinity pharmaceuticals, inc. is to discover, develop, and deliver to patients best-in-class medicines for the treatment of difficult-to-treat diseases, with a strong focus in oncology and inflammation. small molecule discovery and development capabilities infinity’s programs arise from the integration of a broad range of research and development capabilities, including ... read more

COMPANY PROFILE

Sector

Manufacturing

Industry

Pharmaceutical Preparation Manufacturing

CEO Compensation (Base)

$689,585

CEO Compensation (Total)

$2.53M

URL

Address

1100 Massachusetts Ave Ste 4, Massachusetts, Cambridge, 02138-5241.

Sector

Manufacturing

Industry

Pharmaceutical Preparation Manufacturing

CEO

Adelene Perkins

CEO Compensation (Base)

$689,585

CEO Compensation (Total)

$2.53M

URL

Address

1100 Massachusetts Ave Ste 4, Massachusetts, Cambridge, 02138-5241.

PRICE CHART FOR INFINITY PHARMACEUTICALS INC.

1w

1m

3m

6m

YTD

1y

5y

MAX

From: To:

NEWS

INSIDEARBITRAGE ARTICLES

KEY STATS

Open

$0.10

Previous Close

$0.02

Days Range

$0.01 - $0.02

52 week range

- - -

Volume

1,141,812

Avg. Volume (30 days)

0

Market Cap

-

Dividend Yield

-

P/E

-

Shares Outstanding

90,761,081

Open

$0.10

Previous Close

$0.02

Days Range

$0.01 - $0.02

52 week range

- - -

Volume

1,141,812

Avg. Volume (30 days)

0

Market Cap

-

Dividend Yield

-

P/E

-

Shares Outstanding

90,761,081

FINANCIAL STATEMENTS FOR INFINITY PHARMACEUTICALS INC.

LOADING...

Open in:

Open in:

INSIDER TRANSACTIONS FOR INFINITY PHARMACEUTICALS INC.

Owner	Relationship	Date	Transaction	Cost	# Shares	Value($)	Total Shares	Form 4
Perkins Adelene Q	Director	Sep 12, 2023	Sale	$0.07	410,196	28,714	1,175,291	Sep 12, 2023, 06:20 PM
Peluso Stephane	Chief Scientific Officer	Aug 02, 2022	Sale	$0.66	14,994	9,932	37,052	Aug 04, 2022, 06:26 PM
EVNIN ANTHONY B	Director	Jun 16, 2022	Option Exercise	$0.68	46,378	31,491	215,403	Jun 16, 2022, 09:29 PM
SCHWARTZ BRIAN	Director	Jun 16, 2022	Option Exercise	$0.68	30,919	20,994	30,919	Jun 16, 2022, 08:32 PM
BEIER DAVID W	Director	Jun 10, 2021	Option Exercise	$3.43	3,061	10,499	8,775	Jun 11, 2021, 04:17 PM
BVF PARTNERS L P/IL	10% Owner	Feb 11, 2021	Sale	$5.37	2,260,085	12,133,492	4,448,421	Feb 16, 2021, 04:35 PM
BVF PARTNERS L P/IL	10% Owner	Jan 22, 2021	Sale	$4.14	5,848,520	24,205,855	5,663,912	Jan 26, 2021, 05:27 PM
EVNIN ANTHONY B	Director	Jun 13, 2019	Option Exercise	$1.60	13,125	21,000	143,138	Jun 14, 2019, 04:06 PM
Berkowitz Jeffrey	Director	Jun 13, 2019	Option Exercise	$1.60	26,250	42,000	85,238	Jun 14, 2019, 04:05 PM
BVF PARTNERS L P/IL	10% Owner	Dec 13, 2018	Buy	$1.20	175,000	209,912	8,485,575	Dec 17, 2018, 07:40 PM
BVF PARTNERS L P/IL	10% Owner	Nov 28, 2018	Buy	$1.30	100,000	130,000	6,510,597	Nov 30, 2018, 06:28 PM
BVF PARTNERS L P/IL	10% Owner	Nov 21, 2018	Buy	$1.35	4,700	6,345	8,431,114	Nov 21, 2018, 05:57 PM
BVF PARTNERS L P/IL	10% Owner	Nov 19, 2018	Buy	$1.37	1,465,126	2,005,076	8,426,995	Nov 21, 2018, 05:57 PM
BVF PARTNERS L P/IL	10% Owner	Nov 15, 2018	Buy	$1.35	91,474	123,490	7,643,800	Nov 15, 2018, 08:07 PM
BVF PARTNERS L P/IL	10% Owner	Nov 14, 2018	Buy	$1.34	210,250	281,735	7,591,400	Nov 15, 2018, 08:07 PM
BVF PARTNERS L P/IL	10% Owner	Nov 13, 2018	Buy	$1.35	604,208	815,681	7,474,110	Nov 15, 2018, 08:07 PM
Perkins Adelene Q	Chief Executive Officer	Oct 01, 2018	Sale	$2.82	5,000	14,100	609,561	Oct 02, 2018, 04:30 PM
Kutok Jeffery	Chief Scientific Officer	Aug 16, 2018	Sale	$2.00	6,133	12,266	0	Aug 17, 2018, 04:05 PM
Kutok Jeffery	Chief Scientific Officer	Aug 15, 2018	Sale	$2.01	8,180	16,421	6,133	Aug 17, 2018, 04:05 PM
Kutok Jeffery	Chief Scientific Officer	Jun 22, 2018	Sale	$2.00	14,313	28,695	14,313	Jun 25, 2018, 05:00 PM
BVF PARTNERS L P/IL	10% Owner	Jun 21, 2018	Buy	$1.65	425,531	702,126	7,432,656	Jun 21, 2018, 06:57 PM
BVF PARTNERS L P/IL	10% Owner	Jun 19, 2018	Buy	$1.65	3,516,560	5,802,324	7,202,101	Jun 21, 2018, 06:57 PM
Berkowitz Jeffrey	Director	Jun 12, 2018	Option Exercise	$1.75	22,857	40,000	58,988	Jun 14, 2018, 08:35 AM
SMITH IAN F	Director	Jun 12, 2018	Option Exercise	$1.75	22,857	40,000	45,845	Jun 14, 2018, 08:34 AM
EVNIN ANTHONY B	Director	Jun 12, 2018	Option Exercise	$1.75	11,428	19,999	130,013	Jun 14, 2018, 08:33 AM
BEIER DAVID W	Director	Jun 12, 2018	Option Exercise	$1.75	5,714	10,000	5,714	Jun 14, 2018, 08:30 AM
BVF PARTNERS L P/IL	10% Owner	Apr 10, 2018	Buy	$2.00	1,010,000	2,020,000	5,285,341	Apr 11, 2018, 06:01 PM
BVF PARTNERS L P/IL	10% Owner	Apr 09, 2018	Buy	$1.90	500,000	950,000	4,738,476	Apr 11, 2018, 06:01 PM
Perkins Adelene Q	Chief Executive Officer	Mar 05, 2018	Sale	$2.78	5,000	13,890	607,252	Mar 07, 2018, 04:22 PM
BLOCH LAWRENCE E	President	Dec 06, 2017	Buy	$1.81	500,000	905,000	580,944	Dec 07, 2017, 09:11 AM
BVF PARTNERS L P/IL	10% Owner	Oct 04, 2017	Buy	$1.28	653,449	839,029	4,509,785	Oct 05, 2017, 08:07 PM
BVF PARTNERS L P/IL	10% Owner	Oct 03, 2017	Buy	$1.24	946,597	1,169,047	4,154,704	Oct 05, 2017, 08:07 PM
Berkowitz Jeffrey	Director	May 25, 2017	Option Exercise	$1.74	5,747	10,000	36,131	May 26, 2017, 08:28 AM
EVNIN ANTHONY B	Director	May 25, 2017	Option Exercise	$1.74	11,494	20,000	118,585	May 26, 2017, 08:26 AM
SMITH IAN F	Director	May 25, 2017	Option Exercise	$1.74	22,988	39,999	22,988	May 26, 2017, 08:23 AM
VENUTI MICHAEL C	Director	Mar 17, 2017	Sale	$3.48	6,250	21,750	50,000	Mar 20, 2017, 04:10 PM
BVF PARTNERS L P/IL	10% Owner	Jan 03, 2017	Buy	$1.34	4,379	5,867	3,631,103	Jan 05, 2017, 05:30 PM
BVF PARTNERS L P/IL	10% Owner	Dec 30, 2016	Buy	$1.34	3,553	4,760	3,629,958	Dec 30, 2016, 05:37 PM
BVF PARTNERS L P/IL	10% Owner	Dec 28, 2016	Buy	$1.34	738,848	986,805	3,627,610	Dec 30, 2016, 05:37 PM
BVF PARTNERS L P/IL	10% Owner	Dec 20, 2016	Buy	$1.35	22,001	29,809	3,225,884	Dec 20, 2016, 06:26 PM
BVF PARTNERS L P/IL	10% Owner	Dec 19, 2016	Buy	$1.36	198,264	269,322	3,214,238	Dec 20, 2016, 06:26 PM
BVF PARTNERS L P/IL	10% Owner	Dec 16, 2016	Buy	$1.28	434,656	556,360	3,106,036	Dec 20, 2016, 06:26 PM
KANGO SUJAY	Chief Commercial Officer	Dec 13, 2016	Sale	$1.27	49,991	63,259	50,292	Dec 14, 2016, 05:16 PM
KANGO SUJAY	Chief Commercial Officer	Dec 12, 2016	Sale	$1.30	25,009	32,612	50,590	Dec 14, 2016, 05:16 PM
BVF PARTNERS L P/IL	10% Owner	Dec 02, 2016	Buy	$1.19	52,500	62,480	2,869,643	Dec 02, 2016, 05:50 PM
BVF PARTNERS L P/IL	10% Owner	Dec 01, 2016	Buy	$1.18	148,894	176,365	2,838,645	Dec 02, 2016, 05:50 PM
EVNIN ANTHONY B	Director	Jun 17, 2016	Option Exercise	$1.52	13,157	19,999	107,091	Jun 21, 2016, 05:53 PM
LANDER ERIC S	Director	Jun 17, 2016	Option Exercise	$1.52	6,578	9,999	80,319	Jun 21, 2016, 05:53 PM
Berkowitz Jeffrey	Director	Jun 17, 2016	Option Exercise	$1.52	26,315	39,999	30,384	Jun 21, 2016, 05:52 PM
LANDER ERIC S	Director	Sep 01, 2015	Option Exercise	$8.60	2,034	17,492	73,741	Sep 03, 2015, 04:17 PM
EVNIN ANTHONY B	Director	Sep 01, 2015	Option Exercise	$8.60	2,034	17,492	93,934	Sep 03, 2015, 04:16 PM
Berkowitz Jeffrey	Director	Sep 01, 2015	Option Exercise	$8.60	4,069	34,993	4,069	Sep 03, 2015, 04:15 PM
Perkins Adelene Q	President & CEO	Jun 25, 2015	Sale	$10.93	5,000	54,650	359,432	Jun 26, 2015, 04:15 PM
Palombella Vito J.	Chief Scientific Officer	Jun 15, 2015	Sale	$10.97	4,737	51,965	868	Jun 16, 2015, 04:15 PM
Perkins Adelene Q	President & CEO	May 27, 2015	Sale	$12.81	10,000	128,100	364,432	May 28, 2015, 04:16 PM
Perkins Adelene Q	President & CEO	May 14, 2015	Sale	$12.18	10,000	121,800	374,432	May 15, 2015, 04:28 PM
Palombella Vito J.	Chief Scientific Officer	Apr 30, 2015	Option Exercise	$2.04	4,737	9,663	5,605	May 01, 2015, 04:42 PM
Perkins Adelene Q	President & CEO	Mar 16, 2015	Sale	$16.00	20,000	320,000	384,432	Mar 17, 2015, 05:40 PM
Perkins Adelene Q	President & CEO	Mar 05, 2015	Sale	$16.50	25,000	412,500	404,432	Mar 09, 2015, 05:36 PM
Perkins Adelene Q	President & CEO	Jan 29, 2015	Sale	$14.83	20,000	296,536	429,432	Mar 09, 2015, 05:34 PM
Perkins Adelene Q	President & CEO	Jan 29, 2015	Sale	$14.83	20,000	296,536	427,535	Feb 02, 2015, 04:15 PM
Palombella Vito J.	Chief Scientific Officer	Dec 15, 2014	Option Exercise	$2.04	4,737	9,663	4,737	Dec 16, 2014, 07:44 PM
Palombella Vito J.	Chief Scientific Officer	Dec 15, 2014	Sale	$16.32	4,737	77,294	0	Dec 16, 2014, 07:44 PM
Palombella Vito J.	Chief Scientific Officer	Nov 26, 2014	Option Exercise	$2.04	4,736	9,661	4,736	Nov 28, 2014, 04:15 PM
Palombella Vito J.	Chief Scientific Officer	Nov 26, 2014	Sale	$15.00	4,736	71,040	0	Nov 28, 2014, 04:15 PM
EVNIN ANTHONY B	Director	Oct 03, 2014	Option Exercise	$12.56	24,500	307,765	91,900	Oct 06, 2014, 04:06 PM
EVNIN ANTHONY B	Director	Sep 30, 2014	Sale	$13.56	112,451	1,525,229	0	Oct 02, 2014, 04:05 PM
Palombella Vito J.	Chief Scientific Officer	Sep 03, 2014	Option Exercise	$2.04	9,472	19,323	9,472	Sep 05, 2014, 04:05 PM
Palombella Vito J.	Chief Scientific Officer	Sep 03, 2014	Sale	$15.39	9,472	145,774	0	Sep 05, 2014, 04:05 PM
Palombella Vito J.	Chief Scientific Officer	Jun 30, 2014	Option Exercise	$10.83	879	9,520	879	Jul 02, 2014, 06:20 PM
Palombella Vito J.	Chief Scientific Officer	Jul 01, 2014	Sale	$12.87	879	11,313	0	Jul 02, 2014, 06:20 PM
SELBY NORMAN C	Director	Mar 06, 2014	Option Exercise	$8.87	2,500	22,175	10,000	Mar 10, 2014, 05:26 PM
Palombella Vito J.	Chief Scientific Officer	Feb 25, 2014	Option Exercise	$2.04	4,736	9,661	4,736	Feb 27, 2014, 04:05 PM
Palombella Vito J.	Chief Scientific Officer	Feb 25, 2014	Sale	$15.00	4,736	71,040	0	Feb 27, 2014, 04:05 PM
Palombella Vito J.	Chief Scientific Officer	Dec 31, 2013	Option Exercise	$11.74	753	8,840	753	Jan 06, 2014, 04:30 PM
Palombella Vito J.	Chief Scientific Officer	Jan 02, 2014	Sale	$13.52	753	10,181	0	Jan 06, 2014, 04:30 PM
EVNIN ANTHONY B	Director	Dec 02, 2013	Sale	$14.56	17,756	258,527	112,451	Dec 04, 2013, 04:30 PM
EVNIN ANTHONY B	Director	Nov 25, 2013	Sale	$15.40	23,703	365,026	270,368	Nov 27, 2013, 04:40 PM
EVNIN ANTHONY B	Director	Nov 27, 2013	Sale	$14.56	1,200	17,472	130,207	Nov 27, 2013, 04:40 PM
EVNIN ANTHONY B	Director	Nov 26, 2013	Sale	$14.72	138,961	2,045,506	131,407	Nov 27, 2013, 04:40 PM
Palombella Vito J.	Chief Scientific Officer	Sep 27, 2013	Option Exercise	$2.04	4,736	9,661	4,736	Sep 30, 2013, 06:52 PM
Palombella Vito J.	Chief Scientific Officer	Sep 27, 2013	Sale	$17.28	4,736	81,837	0	Sep 30, 2013, 06:52 PM
Perkins Adelene Q	Pres & Chief Executive Officer	Sep 13, 2013	Sale	$20.50	13,076	268,096	447,535	Sep 13, 2013, 06:00 PM
Perkins Adelene Q	Pres & Chief Executive Officer	Sep 12, 2013	Sale	$20.81	31,924	664,390	460,611	Sep 13, 2013, 06:00 PM
Palombella Vito J.	Chief Scientific Officer	Jun 20, 2013	Option Exercise	$1.72	22,103	38,017	23,150	Jun 21, 2013, 04:30 PM
Palombella Vito J.	Chief Scientific Officer	Jun 20, 2013	Sale	$18.53	23,150	429,067	0	Jun 21, 2013, 04:30 PM
Beacon Co	10% Owner	Apr 16, 2013	Sale	$38.40	5,708,282	219,198,038	0	Apr 16, 2013, 04:13 PM
Rosebay Medical Co L.P.	10% Owner	Apr 16, 2013	Sale	$38.40	5,708,283	219,198,076	0	Apr 16, 2013, 04:12 PM
VENUTI MICHAEL C	Director	Mar 06, 2013	Option Exercise	$16.80	6,250	105,000	56,250	Mar 07, 2013, 04:17 PM
SELBY NORMAN C	Director	Dec 14, 2012	Option Exercise	$8.87	2,500	22,175	7,500	Dec 18, 2012, 04:31 PM
Perkins Adelene Q	Pres & Chief Executive Officer	Dec 07, 2012	Option Exercise	$7.27	175,997	1,279,198	492,535	Dec 10, 2012, 07:05 PM
EVNIN ANTHONY B	Director	Nov 27, 2012	Sale	$25.28	17,648	446,171	298,903	Nov 29, 2012, 04:12 PM
EVNIN ANTHONY B	Director	Nov 29, 2012	Sale	$24.62	4,832	118,958	294,071	Nov 29, 2012, 04:12 PM
EVNIN ANTHONY B	Director	Nov 27, 2012	Option Exercise	$6.95	58,657	407,724	59,580	Nov 28, 2012, 04:48 PM
Lindblom Christopher M	See Remarks	Nov 26, 2012	Option Exercise	$13.06	13,885	181,373	13,885	Nov 27, 2012, 06:27 PM
Lindblom Christopher M	See Remarks	Nov 26, 2012	Sale	$25.73	13,885	357,272	0	Nov 27, 2012, 06:27 PM
SELBY NORMAN C	Director	Oct 15, 2012	Option Exercise	$8.87	5,000	44,350	5,000	Oct 16, 2012, 06:37 PM
Rosebay Medical Co L.P.	10% Owner	Sep 07, 2012	Buy	$14.50	5,416,565	78,540,193	5,416,565	Sep 11, 2012, 05:40 PM
Beacon Co	10% Owner	Sep 07, 2012	Buy	$14.50	5,416,565	78,540,193	5,416,565	Sep 11, 2012, 05:40 PM
Santabarbara Pedro	Chief Medical Officer	Sep 04, 2012	Option Exercise	$6.50	9,200	59,800	9,200	Sep 06, 2012, 04:10 PM
Holtzman Steven H	Director	May 31, 2012	Sale	$13.01	57,573	749,025	0	Jun 04, 2012, 05:23 PM
Holtzman Steven H	Director	May 30, 2012	Sale	$13.00	10,958	142,454	57,573	May 31, 2012, 05:58 PM
Holtzman Steven H	Director	May 29, 2012	Sale	$13.00	189,303	2,460,939	68,531	May 31, 2012, 05:58 PM
Perkins Adelene Q	Pres & Chief Executive Officer	Dec 16, 2010	Buy	$6.10	25,000	152,569	316,538	Dec 17, 2010, 08:45 AM
Perkins Adelene Q	Pres & Chief Executive Officer	Aug 25, 2010	Buy	$4.99	5,349	26,692	291,538	Aug 26, 2010, 11:38 AM
Perkins Adelene Q	Pres & Chief Executive Officer	Aug 24, 2010	Buy	$4.89	44,651	218,343	286,189	Aug 26, 2010, 11:38 AM

Load More Insider Transactions

Buy Sale Option Exercise

Owner	Relationship	Date	Value($)
Perkins Adelene Q	Director	09/12/2023	28,714
Peluso Stephane	Chief Scientific Officer	08/02/2022	9,932
EVNIN ANTHONY B	Director	06/16/2022	31,491
SCHWARTZ BRIAN	Director	06/16/2022	20,994
BEIER DAVID W	Director	06/10/2021	10,499
BVF PARTNERS L P/IL	10% Owner	02/11/2021	12,133,492
BVF PARTNERS L P/IL	10% Owner	01/22/2021	24,205,855
EVNIN ANTHONY B	Director	06/13/2019	21,000
Berkowitz Jeffrey	Director	06/13/2019	42,000
BVF PARTNERS L P/IL	10% Owner	12/13/2018	209,912
BVF PARTNERS L P/IL	10% Owner	11/28/2018	130,000
BVF PARTNERS L P/IL	10% Owner	11/21/2018	6,345
BVF PARTNERS L P/IL	10% Owner	11/19/2018	2,005,076
BVF PARTNERS L P/IL	10% Owner	11/15/2018	123,490
BVF PARTNERS L P/IL	10% Owner	11/14/2018	281,735
BVF PARTNERS L P/IL	10% Owner	11/13/2018	815,681
Perkins Adelene Q	Chief Executive Officer	10/01/2018	14,100
Kutok Jeffery	Chief Scientific Officer	08/16/2018	12,266
Kutok Jeffery	Chief Scientific Officer	08/15/2018	16,421
Kutok Jeffery	Chief Scientific Officer	06/22/2018	28,695
BVF PARTNERS L P/IL	10% Owner	06/21/2018	702,126
BVF PARTNERS L P/IL	10% Owner	06/19/2018	5,802,324
Berkowitz Jeffrey	Director	06/12/2018	40,000
SMITH IAN F	Director	06/12/2018	40,000
EVNIN ANTHONY B	Director	06/12/2018	19,999
BEIER DAVID W	Director	06/12/2018	10,000
BVF PARTNERS L P/IL	10% Owner	04/10/2018	2,020,000
BVF PARTNERS L P/IL	10% Owner	04/09/2018	950,000
Perkins Adelene Q	Chief Executive Officer	03/05/2018	13,890
BLOCH LAWRENCE E	President	12/06/2017	905,000
BVF PARTNERS L P/IL	10% Owner	10/04/2017	839,029
BVF PARTNERS L P/IL	10% Owner	10/03/2017	1,169,047
Berkowitz Jeffrey	Director	05/25/2017	10,000
EVNIN ANTHONY B	Director	05/25/2017	20,000
SMITH IAN F	Director	05/25/2017	39,999
VENUTI MICHAEL C	Director	03/17/2017	21,750
BVF PARTNERS L P/IL	10% Owner	01/03/2017	5,867
BVF PARTNERS L P/IL	10% Owner	12/30/2016	4,760
BVF PARTNERS L P/IL	10% Owner	12/28/2016	986,805
BVF PARTNERS L P/IL	10% Owner	12/20/2016	29,809
BVF PARTNERS L P/IL	10% Owner	12/19/2016	269,322
BVF PARTNERS L P/IL	10% Owner	12/16/2016	556,360
KANGO SUJAY	Chief Commercial Officer	12/13/2016	63,259
KANGO SUJAY	Chief Commercial Officer	12/12/2016	32,612
BVF PARTNERS L P/IL	10% Owner	12/02/2016	62,480
BVF PARTNERS L P/IL	10% Owner	12/01/2016	176,365
EVNIN ANTHONY B	Director	06/17/2016	19,999
LANDER ERIC S	Director	06/17/2016	9,999
Berkowitz Jeffrey	Director	06/17/2016	39,999
LANDER ERIC S	Director	09/01/2015	17,492
EVNIN ANTHONY B	Director	09/01/2015	17,492
Berkowitz Jeffrey	Director	09/01/2015	34,993
Perkins Adelene Q	President & CEO	06/25/2015	54,650
Palombella Vito J.	Chief Scientific Officer	06/15/2015	51,965
Perkins Adelene Q	President & CEO	05/27/2015	128,100
Perkins Adelene Q	President & CEO	05/14/2015	121,800
Palombella Vito J.	Chief Scientific Officer	04/30/2015	9,663
Perkins Adelene Q	President & CEO	03/16/2015	320,000
Perkins Adelene Q	President & CEO	03/05/2015	412,500
Perkins Adelene Q	President & CEO	01/29/2015	296,536
Perkins Adelene Q	President & CEO	01/29/2015	296,536
Palombella Vito J.	Chief Scientific Officer	12/15/2014	9,663
Palombella Vito J.	Chief Scientific Officer	12/15/2014	77,294
Palombella Vito J.	Chief Scientific Officer	11/26/2014	9,661
Palombella Vito J.	Chief Scientific Officer	11/26/2014	71,040
EVNIN ANTHONY B	Director	10/03/2014	307,765
EVNIN ANTHONY B	Director	09/30/2014	1,525,229
Palombella Vito J.	Chief Scientific Officer	09/03/2014	19,323
Palombella Vito J.	Chief Scientific Officer	09/03/2014	145,774
Palombella Vito J.	Chief Scientific Officer	06/30/2014	9,520
Palombella Vito J.	Chief Scientific Officer	07/01/2014	11,313
SELBY NORMAN C	Director	03/06/2014	22,175
Palombella Vito J.	Chief Scientific Officer	02/25/2014	9,661
Palombella Vito J.	Chief Scientific Officer	02/25/2014	71,040
Palombella Vito J.	Chief Scientific Officer	12/31/2013	8,840
Palombella Vito J.	Chief Scientific Officer	01/02/2014	10,181
EVNIN ANTHONY B	Director	12/02/2013	258,527
EVNIN ANTHONY B	Director	11/25/2013	365,026
EVNIN ANTHONY B	Director	11/27/2013	17,472
EVNIN ANTHONY B	Director	11/26/2013	2,045,506
Palombella Vito J.	Chief Scientific Officer	09/27/2013	9,661
Palombella Vito J.	Chief Scientific Officer	09/27/2013	81,837
Perkins Adelene Q	Pres & Chief Executive Officer	09/13/2013	268,096
Perkins Adelene Q	Pres & Chief Executive Officer	09/12/2013	664,390
Palombella Vito J.	Chief Scientific Officer	06/20/2013	38,017
Palombella Vito J.	Chief Scientific Officer	06/20/2013	429,067
Beacon Co	10% Owner	04/16/2013	219,198,038
Rosebay Medical Co L.P.	10% Owner	04/16/2013	219,198,076
VENUTI MICHAEL C	Director	03/06/2013	105,000
SELBY NORMAN C	Director	12/14/2012	22,175
Perkins Adelene Q	Pres & Chief Executive Officer	12/07/2012	1,279,198
EVNIN ANTHONY B	Director	11/27/2012	446,171
EVNIN ANTHONY B	Director	11/29/2012	118,958
EVNIN ANTHONY B	Director	11/27/2012	407,724
Lindblom Christopher M	See Remarks	11/26/2012	181,373
Lindblom Christopher M	See Remarks	11/26/2012	357,272
SELBY NORMAN C	Director	10/15/2012	44,350
Rosebay Medical Co L.P.	10% Owner	09/07/2012	78,540,193
Beacon Co	10% Owner	09/07/2012	78,540,193
Santabarbara Pedro	Chief Medical Officer	09/04/2012	59,800
Holtzman Steven H	Director	05/31/2012	749,025
Holtzman Steven H	Director	05/30/2012	142,454
Holtzman Steven H	Director	05/29/2012	2,460,939
Perkins Adelene Q	Pres & Chief Executive Officer	12/16/2010	152,569
Perkins Adelene Q	Pres & Chief Executive Officer	08/25/2010	26,692
Perkins Adelene Q	Pres & Chief Executive Officer	08/24/2010	218,343

Load More Insider Transactions

CHANGE IN SHARES OUTSTANDING FOR INFINITY PHARMACEUTICALS INC.

STOCK BUYBACKS FOR INFINITY PHARMACEUTICALS INC.

Period of Report

Previous Period

% Change in Shares

10-K/10-Q Filings

Quarter

06/30/2023

03/31/2023

0.53%

1Q

06/30/2023

12/31/2022

0.59%

2Q

06/30/2023

09/30/2022

0.55%

3Q

06/30/2023

06/30/2022

0.81%

4Q

06/30/2023

03/31/2022

0.82%

5Q

06/30/2023

12/31/2021

0.89%

6Q

06/30/2023

09/30/2021

1.26%

7Q

06/30/2023

06/30/2021

1.38%

8Q

06/30/2023

03/31/2021

18.69%

9Q

06/30/2023

12/31/2020

40.19%

10Q

06/30/2023

09/30/2020

48.56%

11Q

Period of Report: 06/30/2023

10-K/10-Q Filings: View

Previous Period

% Change in Shares

Quarter

03/31/2023

0.53%

1Q

12/31/2022

0.59%

2Q

09/30/2022

0.55%

3Q

06/30/2022

0.81%

4Q

03/31/2022

0.82%

5Q

12/31/2021

0.89%

6Q

09/30/2021

1.26%

7Q

06/30/2021

1.38%

8Q

03/31/2021

18.69%

9Q

12/31/2020

40.19%

10Q

09/30/2020

48.56%

11Q

BUYBACK ANNOUNCEMENT(S) FOR INFINITY PHARMACEUTICALS INC.

Active Completed

LOADING...